ChemPartner PharmaTech Co Ltd (300149) - Total Assets

Latest as of March 2026: CN¥2.04 Billion CNY ≈ $298.52 Million USD

Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) holds total assets worth CN¥2.04 Billion CNY (≈ $298.52 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

ChemPartner PharmaTech Co Ltd - Total Assets Trend (2007–2025)

This chart illustrates how ChemPartner PharmaTech Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 300149 stock market capitalisation for the company's overall valuation and market capitalisation.

ChemPartner PharmaTech Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

ChemPartner PharmaTech Co Ltd's total assets of CN¥2.04 Billion consist of 37.6% current assets and 62.4% non-current assets. Review 300149 total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	20.3%
Accounts Receivable	CN¥229.26 Million	11.3%
Inventory	CN¥9.47 Million	0.5%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥32.69 Million	1.6%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2007–2025)

This chart illustrates how ChemPartner PharmaTech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See ChemPartner PharmaTech Co Ltd stock price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: ChemPartner PharmaTech Co Ltd's current assets represent 37.6% of total assets in 2025, an increase from 0.0% in 2007.
Cash Position: Cash and equivalents constituted 20.3% of total assets in 2025, down from 33.4% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 4.0% in 2007.
Asset Diversification: The largest asset category is accounts receivable at 11.3% of total assets.

ChemPartner PharmaTech Co Ltd Competitors by Total Assets

Key competitors of ChemPartner PharmaTech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	USA	$2.19 Billion
Halozyme Therapeutics Inc NASDAQ:HALO	USA	$2.22 Billion
Tubize-Fin BR:TUB	Belgium	€1.99 Billion
Beijing Tiantan Biological Products Corp Ltd SHG:600161	China	CN¥16.55 Billion
Rapport Therapeutics, Inc. Common Stock NASDAQ:RAPP	USA	$458.98 Million
Galecto Inc NASDAQ:GLTO	USA	$535.44 Million
Chengdu Kanghua Biological Products SHE:300841	China	CN¥3.94 Billion
Guangzhou Boji Medical and Biotechnological Co Ltd SHE:300404	China	CN¥1.67 Billion

ChemPartner PharmaTech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.13	1.94	1.12
Quick Ratio	2.09	1.89	1.07
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥419.25 Million	CN¥312.20 Million	CN¥102.30 Million

ChemPartner PharmaTech Co Ltd - Advanced Valuation Insights

This section examines the relationship between ChemPartner PharmaTech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.28
Latest Market Cap to Assets Ratio	0.32
Asset Growth Rate (YoY)	1.9%
Total Assets	CN¥2.03 Billion
Market Capitalization	$650.71 Million USD

Valuation Analysis

Below Book Valuation: The market values ChemPartner PharmaTech Co Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: ChemPartner PharmaTech Co Ltd's assets grew by 1.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for ChemPartner PharmaTech Co Ltd (2007–2025)

The table below shows the annual total assets of ChemPartner PharmaTech Co Ltd from 2007 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.03 Billion ≈ $297.48 Million	+1.86%
2024-12-31	CN¥2.00 Billion ≈ $292.05 Million	-18.01%
2023-12-31	CN¥2.43 Billion ≈ $356.22 Million	-36.34%
2022-12-31	CN¥3.82 Billion ≈ $559.56 Million	-9.33%
2021-12-31	CN¥4.22 Billion ≈ $617.17 Million	+2.33%
2020-12-31	CN¥4.12 Billion ≈ $603.12 Million	+9.39%
2019-12-31	CN¥3.77 Billion ≈ $551.34 Million	+12.55%
2018-12-31	CN¥3.35 Billion ≈ $489.87 Million	+220.91%
2017-12-31	CN¥1.04 Billion ≈ $152.65 Million	+31.52%
2016-12-31	CN¥793.16 Million ≈ $116.06 Million	+4.92%
2015-12-31	CN¥756.00 Million ≈ $110.63 Million	+2.01%
2014-12-31	CN¥741.13 Million ≈ $108.45 Million	+5.28%
2013-12-31	CN¥703.99 Million ≈ $103.02 Million	+5.45%
2012-12-31	CN¥667.61 Million ≈ $97.69 Million	+5.33%
2011-12-31	CN¥633.82 Million ≈ $92.75 Million	+7.90%
2010-12-31	CN¥587.42 Million ≈ $85.96 Million	+330.98%
2009-12-31	CN¥136.30 Million ≈ $19.94 Million	+56.79%
2008-12-31	CN¥86.93 Million ≈ $12.72 Million	+28.24%
2007-12-31	CN¥67.79 Million ≈ $9.92 Million	--

About ChemPartner PharmaTech Co Ltd

SHE:300149 China Biotechnology

Market Cap

$650.71 Million

CN¥4.45 Billion CNY

Market Cap Rank

#11050 Global

#3068 in China

Share Price

CN¥8.93

Change (1 day)

-1.54%

52-Week Range

CN¥7.55 - CN¥13.97

All Time High

CN¥24.07